Kevin Church, CHIEF SCIENTIFIC OFFICER at Athira Pharma, Inc. (ATHA), sold 8,510 shares at $0.56 ($5K) on 2025-01-02, disclosed to the SEC on 2025-01-03.
Seasonal sale ($5k) by CHIEF SCIENTIFIC OFFICER — this insider has traded ATHA in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ATHA | SELL | 2025-07-02 | $2K | — | Filing → |
| ATHA | SELL | 2024-09-05 | $1K | — | Filing → |
| ATHA | SELL | 2024-02-16 | $7K | — | Filing → |